Reviews/Artificial Sweeteners/Sweetness-calorie uncoupling disrupts appetite
Appetite · ANSW-APP-02 · v2
Across the direct behavioural trials, giving people sweetness without the matching calories did not drive them to eat more. Several trials found energy intake was unchanged versus water or caloric drinks [1][7], and others found it actually fell [3][5], while one trial [9] concluded that the carbohydrate content, not the sweet taste, is what shapes later appetite. The only study pointing the other way is a brain-imaging trial [4], where a non-caloric sweetener raised blood flow in an appetite-related brain region and acute hunger ratings compared with sugar, but this was not linked to how much the participants went on to eat. The panel therefore saw outcome-level evidence weighing against the idea of disruption, with a single mechanistic signal keeping it from being dismissed entirely. The result is a claim that behaviour contradicts but a neural finding keeps alive.
The most direct behavioural test, a crossover trial with five weeks of habituation, found low-energy-sweetener beverages did not differ from water in total energy intake, macronutrient intake, sweet-food selection or motivational ratings [1]. A 12-week parallel-arm trial found energy intake decreased with sucralose [3], and a crossover trial found total energy intake was lower after a stevia beverage (727 ± 239 kcal) than water (832 ± 198 kcal, P = 0.013) [5]. A reduced-sucrose equi-sweet solution lowered energy intake by 10 ± 7% and led the authors to credit carbohydrate content rather than sweetness [9], while an acesulfame/cyclamate trial reduced prospective consumption but left ad libitum intake unchanged [7]. Against this, a hypothalamic-perfusion trial showed sucralose versus sucrose raised hypothalamic blood flow (P < 0.018) and hunger (P < 0.001) [4]. The contested point: The division is between surrogate mechanism and measured behaviour: [4] shows a hypothalamic-perfusion and acute-hunger signal consistent with disruption, whereas the behavioural trials [1][3][5][7] show no increase, and often a decrease, in food intake. Whether the neural effect in [4] translates into altered eating is exactly what the corpus leaves unresolved, since [4] did not measure food intake.
All 12 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.
We’ll also send you other claims from Artificial Sweeteners, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.
One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.
The one supportive paper [4] reports surrogate hypothalamic-perfusion and acute hunger-rating endpoints, not altered food intake; it does not demonstrate disrupted appetite regulation at the behavioural level.
The strongest behavioural RCTs [1], [5] and [7] show null or beneficial effects on energy intake, directly contradicting the word 'disrupts'.
Where it remains uncertain. The sole supportive result is a hypothalamic blood-flow and hunger signal with sucralose versus sucrose [4], a surrogate the trial never tied to how much participants ate.
Aleatory
Acute crossover designs with few participants ([2] N=18, [5] N=20, [7] N=16-26) carry wide person-to-person variation in appetite and intake.
Epistemic
The hypothalamic-perfusion signal in [4] is acute and untested over repeated exposure, so its downstream effect on eating is unknown.
Inferential
Inferring disrupted appetite regulation from raised hypothalamic blood flow and hunger ratings [4] requires a link to food intake that the corpus does not supply.
The load-bearing papers from a corpus of 12, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.
Largest direct behavioural test finds no disruption of intake or appetite from uncoupling.
“Water and LCS beverage did not differ in their effects on total energy intake, macronutrient intakes or the selection of sweet foods and on motivational ratings.”
Panel auditInternal validity: high · scope of inference: Healthy non-obese French adults (BMI 19-28) who were infrequent LCS consumers, over acute and 5-week exposure.Key limitations: non-obese, LCS-naive population only · Day 2 intake self-reported · beverage comparison, not all LCS types
No behavioural disruption of intake; only a tentative neural adaptation signal.
“Total energy intake at the buffet was not significantly different between WAT and NNS.”
Panel auditInternal validity: medium · scope of inference: Eighteen normal-weight men, acute single exposure; brain-response mechanism plus one-meal intake.Key limitations: n=18, men only · acute single exposure · brain-response differences not tied to a measured intake change
Primary mechanistic support: non-caloric sweetener raises hypothalamic perfusion and hunger versus matched sucrose.
“acute consumption of sucralose versus sucrose stimulates hypothalamic blood flow (P < 0.018) and greater hunger responses (P < 0.001).”
Panel auditInternal validity: high · scope of inference: Young adults across weight categories, acute single exposure; hypothalamic signalling and self-reported hunger.Key limitations: acute single dose, not habitual intake · sucralose vs water produced no hunger difference · hunger is self-reported
12-week trial shows a leading non-caloric sweetener lowered, not raised, energy intake.
“Energy intake decreased with sucralose consumption (P = 0.02)”
Panel auditInternal validity: high · scope of inference: Adults with overweight or obesity over a 12-week beverage intervention; distinguishes individual LCS compounds.Key limitations: LCS effects differ by compound (saccharin behaved like sucrose on weight) · attrition ~20% · beverage-delivered sweeteners only
4 of 12 papers shown. The full review lists all of them, with the panel’s arbitration →
Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.
Behavioural intake data contradict disruption while a single hypothalamic-perfusion trial offers surrogate support, leaving the claim unsupported but not fully refuted.
Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.
Assumptions that carry weight but are not themselves established.
The panel records the gap that would most move the claim, and the study that would close it.
Mechanism-to-intake bridge. The only supportive signal [4] is a hypothalamic-perfusion and hunger surrogate never tied to how much participants ate, which is the crux of the claim. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: A trial pairing hypothalamic perfusion imaging with measured ad libitum energy intake under sucralose versus sucrose to test whether the neural signal predicts eating.
Open question: Does the acute hypothalamic blood-flow and hunger signal seen with sucralose versus sucrose [4] translate into greater subsequent food intake? Why it is still open: [4] measured hypothalamic perfusion and hunger ratings but not food intake, and the behavioural trials that did measure intake found no increase [1][7].
Priors is a sceptical first reader, not peer review, and not medical advice.
Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19